Lerner Neil
11 SEC EDGAR filings indexed (CIK 0001505148) across 3 form types.
Filing profile
Lerner Neil has 11 SEC filings indexed on SecFilingDex, across 3 form types filed over roughly 15 years, from November 5, 2010 to April 30, 2026. The filer is classified under Biological Products (SIC 2836).
Its most frequent disclosure is the Form 4 (Insider transaction) with 8 filings — Statement of changes in beneficial ownership filed by company officers, directors, and 10%+ owners. 3 of these filings were disclosed in the twelve months to April 30, 2026. 1 of the 11 is an amendment (a corrected or updated version of an earlier filing).
Disclosure mix
Profile derived from 11 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.
All filings
- Form 4/AInsider transactionFiled · 0001171843-26-002894
- Form 4Insider transaction · period of report Apr 29, 2026Filed · 0001171843-26-002834
- Form 4Insider transaction · period of report Jan 2, 2026Filed · 0001171843-26-000056
- Form 4Insider transaction · period of report Apr 7, 2025Filed · 0001171843-25-002084
- Form 4Insider transaction · period of report Feb 11, 2025Filed · 0001171843-25-000829
- Form 3Initial insider ownership · period of report Dec 9, 2024Filed · 0001171843-24-006857
- Form 4Insider transaction · period of report Nov 11, 2020Filed · 0001505148-20-000026
- Form 4Insider transaction · period of report May 4, 2020Filed · 0001505148-20-000002
- Form 4Insider transaction · period of report May 3, 2019Filed · 0001373894-19-000038
- Form 4Insider transaction · period of report Apr 30, 2019Filed · 0001373894-19-000021
- Form 3Initial insider ownership · period of report Oct 25, 2010Filed · 0001240679-10-000067
Authoritative source
SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.
Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.